Authors:
HAMMOND LA
ECKARDT JR
GANAPATHI R
BURRIS HA
RODRIGUEZ GA
ECKHARDT SG
ROTHENBERG ML
WEISS GR
KUHN JG
HODGES S
VONHOFF DD
ROWINSKY EK
Citation: La. Hammond et al., A PHASE-I AND TRANSLATIONAL STUDY OF SEQUENTIAL ADMINISTRATION OF THETOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS TOPOTECAN AND ETOPOSIDE, Clinical cancer research, 4(6), 1998, pp. 1459-1467
Authors:
ECKHARDT SG
BAKER SD
ECKARDT JR
BURKE TG
WARNER DL
KUHN JG
RODRIGUEZ G
FIELDS S
THURMAN A
SMITH L
ROTHENBERG ML
WHITE L
WISSEL P
KUNKA R
DEPEE S
LITTLEFIELD D
BURRIS HA
VONHOFF DD
ROWINSKY EK
Citation: Sg. Eckhardt et al., PHASE-I AND PHARMACOKINETIC STUDY OF GI147211, A WATER-SOLUBLE CAMPTOTHECIN ANALOG, ADMINISTERED FOR 5 CONSECUTIVE DAYS EVERY 3 WEEKS, Clinical cancer research, 4(3), 1998, pp. 595-604
Authors:
ECKHARDT SG
BAKER SD
ECKARDT JR
BURKE TG
WARNER DL
KUHN JG
RODRIGUEZ G
FIELDS S
THURMAN A
SMITH L
ROTHENBERG ML
WHITE L
WISSEL P
KUNKA R
DEPEE S
LITTLEFIELD D
BURRIS HA
VONHOFF DD
ROWINSKY EK
Citation: Sg. Eckhardt et al., PHASE-I AND PHARMACOKINETIC STUDY OF GI147211, A WATER-SOLUBLE CAMPTOTHECIN ANALOG, ADMINISTERED FOR 5 CONSECUTIVE DAYS EVERY 3 WEEKS, Clinical cancer research, 4(3), 1998, pp. 595-604
Authors:
ROTHENBERG ML
SHARMA A
WEISS GR
VILLALONACALERO MA
ECKARDT JR
AYLESWORTH C
KRAYNAK MA
RINALDI DA
RODRIGUEZ GI
BURRIS HA
ECKHARDT SG
STEPHENS CD
FORRAL K
NICOL SJ
VONHOFF DD
Citation: Ml. Rothenberg et al., PHASE-I TRIAL OF PACLITAXEL AND GEMCITABINE ADMINISTERED EVERY 2 WEEKS IN PATIENTS WITH REFRACTORY SOLID TUMORS, Annals of oncology, 9(7), 1998, pp. 733-738
Authors:
RAYMOND E
BURRIS HA
ROWINSKY EK
ECKARDT JR
RODRIGUEZ G
SMITH L
WEISS G
VONHOFF DD
Citation: E. Raymond et al., TOPOTECAN IN COMBINATION WITH CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED NON-SMALL-CELL LUNG-CARCINOMA - A PHASE-I STUDY, Annals of oncology, 9, 1998, pp. 266-266
Authors:
BAKER SD
RAVDIN P
AYLESWORTH C
SMETZER L
BRUNO R
VERNILLET L
PAZDUR R
DOYLE G
HAMMERSHAIMB L
HOOKER E
BURRIS HA
ECKHARDT SG
JOHNSON T
KRAYNAK M
HAMMOND L
RODRIGUEZ G
WEISS G
ROWINSKY EK
Citation: Sd. Baker et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF DOCETAXEL IN CANCER-PATIENTS WITH LIVER DYSFUNCTION DUE TO MALIGNANCIES, Annals of oncology, 9, 1998, pp. 388-388
Authors:
HAINSWORTH JD
BURRIS HA
ERLAND JB
THOMAS M
GRECO FA
Citation: Jd. Hainsworth et al., PHASE-I TRIAL OF DOCETAXEL ADMINISTERED BY WEEKLY INFUSION IN PATIENTS WITH ADVANCED REFRACTORY CANCER, Journal of clinical oncology, 16(6), 1998, pp. 2164-2168
Authors:
SCHILSKY RL
HOHNEKER J
RATAIN MJ
JANISCH L
SMETZER L
LUCAS VS
KHOR SP
DIASIO R
VONHOFF DD
BURRIS HA
Citation: Rl. Schilsky et al., PHASE-I CLINICAL AND PHARMACOLOGICAL STUDY OF ENILURACIL PLUS FLUOROURACIL IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 16(4), 1998, pp. 1450-1457
Authors:
VALERO V
JONES SE
VONHOFF DD
BOOSER DJ
MENNEL RG
RAVDIN PM
HOLMES FA
RAHMAN Z
SCHOTTSTAEDT MW
ERBAN JK
ESPARZAGUERRA L
EARHART RH
HORTOBAGYI GN
BURRIS HA
Citation: V. Valero et al., A PHASE-II STUDY OF DOCETAXEL IN PATIENTS WITH PACLITAXEL-RESISTANT METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(10), 1998, pp. 3362-3368
Authors:
BRUNO R
HILLE D
RIVA A
VIVIER N
HUINNINK WWTB
VANOOSTEROM AT
KAYE SB
VERWEIJ J
FOSSELLA FV
VALERO V
RIGAS JR
SEIDMAN AD
CHEVALLIER B
FUMOLEAU P
BURRIS HA
RAVCLIN PM
SHEINER LB
Citation: R. Bruno et al., POPULATION PHARMACOKINETICS PHARMACODYNAMICS OF DOCETAXEL IN PHASE-IISTUDIES IN PATIENTS WITH CANCER/, Journal of clinical oncology, 16(1), 1998, pp. 187-196
Authors:
BURRIS HA
VOGEL CL
CASTRO D
MISHRA L
SCHWARZ M
SPENCER S
OAKES DD
KOREY A
ORENBERG EK
Citation: Ha. Burris et al., INTRATUMORAL CISPLATIN EPINEPHRINE-INJECTABLE GEL AS A PALLIATIVE TREATMENT FOR ACCESSIBLE SOLID TUMORS - A MULTICENTER PILOT-STUDY/, Otolaryngology and head and neck surgery, 118(4), 1998, pp. 496-503
Authors:
BURRIS HA
RAYMOND E
AWADA A
KUHN JG
OROURKE TJ
BRENTZEL J
LYNCH W
KING SYP
BROWN TD
VONHOFF DD
Citation: Ha. Burris et al., PHARMACOKINETIC AND PHASE-I STUDIES OF BREQUINAR (DUP-785, NSC-368390) IN COMBINATION WITH CISPLATIN IN PATIENTS WITH ADVANCED MALIGNANCIES, Investigational new drugs, 16(1), 1998, pp. 19-27
Authors:
PEACOCK NW
BURRIS HA
DIERAS V
SMITH L
RODRIGUEZ GI
ECKARDT JR
JONES SF
HARDY J
HOHNEKER J
BIGLEY J
VONHOFF DD
Citation: Nw. Peacock et al., A PHASE-I TRIAL OF VINORELBINE IN COMBINATION WITH MITOXANTRONE IN PATIENTS WITH REFRACTORY SOLID TUMORS, Investigational new drugs, 16(1), 1998, pp. 37-43
Citation: Fr. Ahmann et al., THE EFFICACY OF GEMCITABINE IN CONTROLLING PAIN AND IMPROVING PERFORMANCE STATUS IN MEN WITH HORMONE-REFRACTORY PROSTATE-CANCER (HRPC), European journal of cancer, 33, 1997, pp. 148-148
Authors:
RAYMOND E
BURRIS HA
ROWINSKY EK
ECKARDT JR
RODRIGUEZ G
SMITH L
WEISS G
VONHOFF DD
Citation: E. Raymond et al., PHASE-I STUDY OF DAILY TIMES 5 TOPOTECAN AND SINGLE INJECTION OF CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED NON-SMALL-CELL LUNG-CARCINOMA, Annals of oncology, 8(10), 1997, pp. 1003-1008
Authors:
BURRIS HA
MOORE MJ
ANDERSEN J
GREEN MR
ROTHENBERG ML
MADIANO MR
CRIPPS MC
PORTENOY RK
STORNIOLO AM
TARASSOFF P
NELSON R
DORR FA
STEPHENS CD
VANHOFF DD
Citation: Ha. Burris et al., IMPROVEMENTS IN SURVIVAL AND CLINICAL BENEFIT WITH GEMCITABINE AS FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED PANCREAS CANCER - A RANDOMIZED TRIAL, Journal of clinical oncology, 15(6), 1997, pp. 2403-2413
Authors:
CREEMERS GJ
GERRITS CJH
ECKARDT JR
SCHELLENS JHM
BURRIS HA
PLANTING AST
RODRIGUEZ GI
LOOS WJ
HUDSON I
BROOM C
VERWEIJ J
VONHOFF DD
Citation: Gj. Creemers et al., PHASE-I AND PHARMACOLOGICAL STUDY OF ORAL TOPOTECAN ADMINISTERED TWICE-DAILY FOR 21 DAYS TO ADULT PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 15(3), 1997, pp. 1087-1093
Authors:
BENEDETTI JK
BURRIS HA
BALCERZAK SP
MACDONALD JS
Citation: Jk. Benedetti et al., PHASE-II TRIAL OF TOPOTECAN IN ADVANCED GASTRIC-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Investigational new drugs, 15(3), 1997, pp. 261-264
Citation: Sf. Jones et Ha. Burris, VINORELBINE - A NEW ANTINEOPLASTIC DRUG FOR THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER, The Annals of pharmacotherapy, 30(5), 1996, pp. 501-506
Authors:
ECKHARDT SG
BURRIS HA
ECKARDT JR
WEISS G
RODRIGUEZ G
ROTHENBERG M
RINALDI D
BARRINGTON R
KUHN JG
MASUO K
SUDO K
ATSUMI R
OGUMA T
HIGASHI L
FIELDS S
SMETZER L
VONHOFF DD
Citation: Sg. Eckhardt et al., A PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF THE ANGIOGENESIS INHIBITOR, TECOGALAN SODIUM, Annals of oncology, 7(5), 1996, pp. 491-496
Authors:
ROTHENBERG ML
MOORE MJ
CRIPPS MC
ANDERSEN JS
PORTENOY RK
BURRIS HA
GREEN MR
TARASSOFF PG
BROWN TD
CASPER ES
STORNIOLO AM
VONHOFF DD
ALBERTS DS
WOLFF R
KELSEN DP
KOCHA W
HALLER DG
MODIANOREVAH M
MOORE M
OKEN MM
SCHILSKY RL
SHAH A
Citation: Ml. Rothenberg et al., A PHASE-II TRIAL OF GEMCITABINE IN PATIENTS WITH 5-FU-REFRACTORY PANCREAS CANCER, Annals of oncology, 7(4), 1996, pp. 347-353
Authors:
ROTHENBERG ML
ECKARDT JR
KUHN JG
BURRIS HA
NELSON J
HILSENBECK SG
RODRIGUEZ GI
THURMAN AM
SMITH LS
ECKHARDT SG
WEISS GR
ELFRING GL
RINALDI DA
SCHAAF LJ
VONHOFF DD
Citation: Ml. Rothenberg et al., PHASE-II TRIAL OF IRINOTECAN IN PATIENTS WITH PROGRESSIVE OR RAPIDLY RECURRENT COLORECTAL-CANCER, Journal of clinical oncology, 14(4), 1996, pp. 1128-1135